190 related articles for article (PubMed ID: 10690988)
21. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
[TBL] [Abstract][Full Text] [Related]
22. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.
Ellis RJ; Moore DJ; Childers ME; Letendre S; McCutchan JA; Wolfson T; Spector SA; Hsia K; Heaton RK; Grant I
Arch Neurol; 2002 Jun; 59(6):923-8. PubMed ID: 12056927
[TBL] [Abstract][Full Text] [Related]
23. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
24. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
[TBL] [Abstract][Full Text] [Related]
25. Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study.
Hammond ER; Crum RM; Treisman GJ; Mehta SH; Clifford DB; Ellis RJ; Gelman BB; Grant I; Letendre SL; Marra CM; Morgello S; Simpson DM; Mcarthur JC;
J Neurovirol; 2016 Aug; 22(4):479-87. PubMed ID: 26727907
[TBL] [Abstract][Full Text] [Related]
26. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.
Marra CM; Zhao Y; Clifford DB; Letendre S; Evans S; Henry K; Ellis RJ; Rodriguez B; Coombs RW; Schifitto G; McArthur JC; Robertson K;
AIDS; 2009 Jul; 23(11):1359-66. PubMed ID: 19424052
[TBL] [Abstract][Full Text] [Related]
27. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
de Almeida SM; Rotta I; Ribeiro CE; Oliveira MF; Chaillon A; de Pereira AP; Cunha AP; Zonta M; Bents JF; Raboni SM; Smith D; Letendre S; Ellis RJ
J Neurovirol; 2017 Jun; 23(3):460-473. PubMed ID: 28247269
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
[TBL] [Abstract][Full Text] [Related]
29. Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection.
Abdulle S; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
AIDS; 2002 Nov; 16(16):2145-9. PubMed ID: 12409735
[TBL] [Abstract][Full Text] [Related]
30. Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals.
De Luca A; Ciancio BC; Larussa D; Murri R; Cingolani A; Rizzo MG; Giancola ML; Ammassari A; Ortona L
Neurology; 2002 Aug; 59(3):342-7. PubMed ID: 12177366
[TBL] [Abstract][Full Text] [Related]
31. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations.
Smith DM; Zárate S; Shao H; Pillai SK; Letendre SL; Wong JK; Richman DD; Frost SD; Ellis RJ;
Virology; 2009 Mar; 385(1):204-8. PubMed ID: 19100592
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.
Yilmaz A; Fuchs D; Hagberg L; Nillroth U; Ståhle L; Svensson JO; Gisslén M
BMC Infect Dis; 2006 Mar; 6():63. PubMed ID: 16566834
[TBL] [Abstract][Full Text] [Related]
33. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
Bogoch II; Davis BT; Venna N
J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.
Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R
J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380
[TBL] [Abstract][Full Text] [Related]
35. A case of multidrug resistance in the central nervous system.
McCarty EJ; Quah SP; Dinsmore WW; Emerson CR
Int J STD AIDS; 2010 Nov; 21(11):777-9. PubMed ID: 21187362
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape.
de Almeida SM; Rotta I; de Pereira AP; Tang B; Umlauf A; Ribeiro CEL; Letendre S; Ellis RJ;
J Neurovirol; 2020 Apr; 26(2):241-251. PubMed ID: 32002817
[TBL] [Abstract][Full Text] [Related]
38. Two phases of HIV RNA decay in CSF during initial days of multidrug therapy.
Haas DW; Johnson BW; Spearman P; Raffanti S; Nicotera J; Schmidt D; Hulgan T; Shepard R; Fiscus SA
Neurology; 2003 Nov; 61(10):1391-6. PubMed ID: 14638961
[TBL] [Abstract][Full Text] [Related]
39. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system.
Price RW; Deeks SG
J Neurovirol; 2004; 10 Suppl 1():44-51. PubMed ID: 14982739
[TBL] [Abstract][Full Text] [Related]
40. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
Valle M; Price RW; Nilsson A; Heyes M; Verotta D
Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
